Correlation Between Corvus Pharmaceuticals and ImmuCell
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and ImmuCell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and ImmuCell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and ImmuCell, you can compare the effects of market volatilities on Corvus Pharmaceuticals and ImmuCell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of ImmuCell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and ImmuCell.
Diversification Opportunities for Corvus Pharmaceuticals and ImmuCell
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Corvus and ImmuCell is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and ImmuCell in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ImmuCell and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with ImmuCell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ImmuCell has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and ImmuCell go up and down completely randomly.
Pair Corralation between Corvus Pharmaceuticals and ImmuCell
Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 2.32 times more return on investment than ImmuCell. However, Corvus Pharmaceuticals is 2.32 times more volatile than ImmuCell. It trades about 0.11 of its potential returns per unit of risk. ImmuCell is currently generating about 0.06 per unit of risk. If you would invest 831.00 in Corvus Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 64.00 from holding Corvus Pharmaceuticals or generate 7.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Corvus Pharmaceuticals vs. ImmuCell
Performance |
| Timeline |
| Corvus Pharmaceuticals |
| ImmuCell |
Corvus Pharmaceuticals and ImmuCell Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corvus Pharmaceuticals and ImmuCell
The main advantage of trading using opposite Corvus Pharmaceuticals and ImmuCell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, ImmuCell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ImmuCell will offset losses from the drop in ImmuCell's long position.| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
| ImmuCell vs. Transgene SA | ImmuCell vs. Alpha Cognition | ImmuCell vs. Fennec Pharmaceuticals | ImmuCell vs. Lipella Pharmaceuticals Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |